{"log_id": 8718347396485052623, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 0.023247, "average": 0.908148, "min": 0.603791}, "location": {"width": 431, "top": 118, "height": 64, "left": 80}, "words": "予增生过长"}, {"probability": {"variance": 0.019559, "average": 0.916528, "min": 0.524469}, "location": {"width": 2250, "top": 187, "height": 68, "left": 80}, "words": "长期一使用垃激囊使子宫内膜增生过长和了宫内膜癌的风险增高(见【不良反应】)非了宫"}, {"probability": {"variance": 0.014768, "average": 0.92632, "min": 0.552426}, "location": {"width": 1517, "top": 259, "height": 64, "left": 80}, "words": "切的女性,每个周期至少加用12天的平激素能大大降低此险"}, {"probability": {"variance": 0.025479, "average": 0.914645, "min": 0.366058}, "location": {"width": 2258, "top": 389, "height": 64, "left": 76}, "words": "在中国注册临床试验中,雌二醇片准二醇地证孕片复合包装210组中见1单纯性子宫内"}, {"probability": {"variance": 0.015531, "average": 0.916634, "min": 0.482686}, "location": {"width": 2250, "top": 458, "height": 72, "left": 68}, "words": "增生过长(161例).对照组中《结合激素0.625mg+酸甲羟平酮2mg)见4例单纯性"}, {"probability": {"variance": 0.031642, "average": 0.862755, "min": 0.460467}, "location": {"width": 683, "top": 531, "height": 64, "left": 80}, "words": "子宫内膜增生过长(1/6例"}, {"probability": {"variance": 0.004936, "average": 0.9515, "min": 0.830002}, "location": {"width": 217, "top": 668, "height": 61, "left": 76}, "words": "出血类型"}, {"probability": {"variance": 0.027351, "average": 0.900548, "min": 0.382845}, "location": {"width": 2189, "top": 733, "height": 68, "left": 80}, "words": "治疗钉始的几个月内可能出现突破性出血和点样出血。若突破性出血或点样出旅在治疗"}, {"probability": {"variance": 0.008197, "average": 0.945815, "min": 0.647436}, "location": {"width": 2246, "top": 810, "height": 61, "left": 76}, "words": "段时间后才发生,或治疗停止后仍持存在,则应请查出血原因,可包子宫内膜活检以除"}, {"probability": {"variance": 0.009074, "average": 0.907212, "min": 0.731373}, "location": {"width": 324, "top": 878, "height": 61, "left": 76}, "words": "子宫内膜悲变"}, {"probability": {"variance": 0.02162, "average": 0.882704, "min": 0.675236}, "location": {"width": 164, "top": 1012, "height": 64, "left": 72}, "words": "乳腺将"}, {"probability": {"variance": 0.031929, "average": 0.886256, "min": 0.366697}, "location": {"width": 2254, "top": 1081, "height": 64, "left": 80}, "words": "一随机慰剂对照试验,女性健求议Wmen' g Iica]th Initative,W,和多个流行病学"}, {"probability": {"variance": 0.025315, "average": 0.889191, "min": 0.411895}, "location": {"width": 2262, "top": 1153, "height": 64, "left": 72}, "words": "研究,包括百万妇女研究 Million Women Study,MWS),都已报道了多年使用雌激素,雌"}, {"probability": {"variance": 0.02562, "average": 0.897663, "min": 0.426146}, "location": {"width": 2147, "top": 1222, "height": 64, "left": 76}, "words": "孕索联合或替物龙作为IRT疗法的女性被诊断为乳的风险增高见【不良反应】1"}, {"probability": {"variance": 0.023564, "average": 0.90078, "min": 0.490359}, "location": {"width": 2227, "top": 1295, "height": 64, "left": 76}, "words": "所有的HRT疗法,在开始使用的几年里。患老乳腺痛的新外风险会变得明显并随治疗时间延"}, {"probability": {"variance": 0.002619, "average": 0.976569, "min": 0.78482}, "location": {"width": 1547, "top": 1364, "height": 61, "left": 80}, "words": "长而开高,但在停止治疗后几年内(最多5年)会回复至基线水平"}, {"probability": {"variance": 0.027219, "average": 0.887535, "min": 0.37332}, "location": {"width": 2246, "top": 1436, "height": 64, "left": 68}, "words": "MWS发現,结合型雌激素(CEE}或二醇E2)在序贷联合或持续联合任何一种液素后均使患"}, {"probability": {"variance": 0.024706, "average": 0.892985, "min": 0.479643}, "location": {"width": 1367, "top": 1505, "height": 64, "left": 76}, "words": "省的乳腺相对风险度变人,且不同给药途径间未见差异"}, {"probability": {"variance": 0.02843, "average": 0.909727, "min": 0.368313}, "location": {"width": 2269, "top": 1574, "height": 64, "left": 76}, "words": "WHI研究中,乳腺癌的发生与所使用的连续联合使用结合型雌激素和酸甲羟CEE+MPA)"}, {"probability": {"variance": 0.03548, "average": 0.879793, "min": 0.358496}, "location": {"width": 1799, "top": 1646, "height": 61, "left": 80}, "words": "小关,与安慰剂组机比,这乳胺癌体积稻有增大更有局部淋巴结转移"}, {"probability": {"variance": 0.030202, "average": 0.891175, "min": 0.382787}, "location": {"width": 2216, "top": 1715, "height": 64, "left": 68}, "words": "HRT,特别是激素-孕囊联合治疗,会增乳房X线检查的影像密度而叮能不利于乳腺"}, {"probability": {"variance": 0.016247, "average": 0.91079, "min": 0.658896}, "location": {"width": 320, "top": 1788, "height": 61, "left": 76}, "words": "放射性检测"}, {"probability": {"variance": 0.003354, "average": 0.908323, "min": 0.815484}, "location": {"width": 324, "top": 1922, "height": 61, "left": 72}, "words": "静脉血栓"}, {"probability": {"variance": 0.030241, "average": 0.888045, "min": 0.422666}, "location": {"width": 2254, "top": 1990, "height": 72, "left": 72}, "words": "HRT疗法与发生静血栓栓塞TE,即深醉脉血栓或肺栓塞)的对危险度升高有关,一随"}, {"probability": {"variance": 0.011526, "average": 0.954405, "min": 0.527187}, "location": {"width": 2254, "top": 2059, "height": 68, "left": 68}, "words": "机对照试验和多个流行病学研究发现,HRT疗法使用者的TE风险比不使用者高2-5倍,预计"}, {"probability": {"variance": 0.038503, "average": 0.877887, "min": 0.350193}, "location": {"width": 2254, "top": 2136, "height": 61, "left": 76}, "words": "不使用HRT疗法者5年内的VTE病例数,在50-59岁女性中约为3例1D人,09岁女性中约为"}, {"probability": {"variance": 0.025236, "average": 0.879534, "min": 0.457526}, "location": {"width": 2262, "top": 2204, "height": 64, "left": 68}, "words": "8例1,00人.预计健康女性使用HRT打法5年里新增YTE病例数为:50-59岁女性中为2-6例最"}, {"probability": {"variance": 0.042152, "average": 0.823132, "min": 0.377311}, "location": {"width": 2246, "top": 2273, "height": 64, "left": 76}, "words": "佳估计值一4),000人,-9岁女性中为5-15例佳估计值=9)1,00人,KT疗法第一年"}, {"probability": {"variance": 0.05078, "average": 0.868472, "min": 0.410904}, "location": {"width": 538, "top": 2346, "height": 57, "left": 80}, "words": "较以后易发生TE"}, {"probability": {"variance": 0.016859, "average": 0.919489, "min": 0.509627}, "location": {"width": 2059, "top": 2414, "height": 61, "left": 175}, "words": "通常公认的vTE危险因子包括个人史或家史,重度肥胖(体重数, Body Mass It"}, {"probability": {"variance": 0.031414, "average": 0.889656, "min": 0.366165}, "location": {"width": 2002, "top": 2487, "height": 61, "left": 179}, "words": "50kg/m2)和系统性红斑(SLE),静曲张在VTE中是否起作用尚无一看法"}, {"probability": {"variance": 0.019723, "average": 0.917836, "min": 0.466011}, "location": {"width": 2143, "top": 2556, "height": 61, "left": 183}, "words": "有VTE史或已知栓形成倾向者发生VTB的风险升商,HKT疗法可能增加此风险。如有个"}, {"probability": {"variance": 0.023179, "average": 0.909717, "min": 0.442093}, "location": {"width": 2147, "top": 2628, "height": 61, "left": 183}, "words": "人或密集的血栓栓塞京族史或复发性自然流产应给予调查以排除血形成频向体质,HRT"}, {"probability": {"variance": 0.011076, "average": 0.93435, "min": 0.47485}, "location": {"width": 2151, "top": 2697, "height": 64, "left": 175}, "words": "疗法在这些病人中应被为禁忌,除非已经彻底评估了血栓形成倾向的危险因子或已开始"}, {"probability": {"variance": 0.022099, "average": 0.906988, "min": 0.428259}, "location": {"width": 1933, "top": 2766, "height": 64, "left": 183}, "words": "抗凝泊疗。对那些早已开始抗凝治疗的女性需仔用考虑使用HT疗法的受-风险"}, {"probability": {"variance": 0.015146, "average": 0.923491, "min": 0.536815}, "location": {"width": 2147, "top": 2842, "height": 57, "left": 183}, "words": "长时间静止不动、重伤或大手术可能会使VTE的风检哲时升高。对所有术后病人均应谨慎"}, {"probability": {"variance": 0.02003, "average": 0.94062, "min": 0.382699}, "location": {"width": 2143, "top": 2904, "height": 64, "left": 179}, "words": "考VTE的预防措以防手术后发生VTE,当选择性手术后可能需长时间静止不动时,尤"}, {"probability": {"variance": 0.017659, "average": 0.929454, "min": 0.42273}, "location": {"width": 2147, "top": 2976, "height": 61, "left": 175}, "words": "其是部或下骨科手术,如有可能应考虑在术4-6周暂时停止HRT治疗只有当女性"}, {"probability": {"variance": 0.019075, "average": 0.918793, "min": 0.533004}, "location": {"width": 985, "top": 3045, "height": 57, "left": 175}, "words": "完全能自主活动后才应重新开始HRT治疗"}, {"probability": {"variance": 0.011707, "average": 0.939791, "min": 0.542073}, "location": {"width": 2147, "top": 3114, "height": 64, "left": 179}, "words": "如使用HRT法后出现静脉血栓栓窍则应停药,应告之患者,若意识到可能为血栓栓塞的"}, {"probability": {"variance": 0.022726, "average": 0.907446, "min": 0.430251}, "location": {"width": 1753, "top": 3183, "height": 64, "left": 179}, "words": "症状(如单疼性水肿,胸部夹发疼,呼吸困难),立即联系医生"}, {"probability": {"variance": 3e-06, "average": 0.998907, "min": 0.994779}, "location": {"width": 256, "top": 3687, "height": 57, "left": 2136}, "words": "1103535"}], "language": 3}